Clinical Trial Update: Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and response to ozanimod in multiple sclerosis has been terminated, per the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ozanimod (ozanimod)

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED